Overall Survival, Health-Related Quality of Life, and Healthcare Resource Use- Independent Analyses from Checkmate 025, A Phase Iii Study of Nivolumab Versus Everolimus in Patients with Advanced or Metastatic Clear-Cell Renal Cell Carcinoma ...
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1520
https://www.valueinhealthjournal.com/article/S1098-3015(16)01588-6/fulltext
Title :
Overall Survival, Health-Related Quality of Life, and Healthcare Resource Use- Independent Analyses from Checkmate 025, A Phase Iii Study of Nivolumab Versus Everolimus in Patients with Advanced or Metastatic Clear-Cell Renal Cell Carcinoma ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01588-6&doi=10.1016/j.jval.2016.03.1520
First page :
A167
Section Title :
Cancer - Health Care Use & Policy Studies
Open access? :
No
Section Order :
415